Healthcare News

Bringing It Home - Innovative Haemodialysis Treatment In Manchester Shortlisted For NICE National Award

June 22, 2017

The home haemodialysis team based at the Manchester Royal Infirmary has implemented an innovative approach for patients on haemodialysis1, which allows them to perform the process in their own homes, avoiding the need for regular visits to hospital for treatment. This programme, shortlisted for a NICE Shared Learning Award2, is currently the largest of its kind in Europe, and is open to all patients in the Manchester area undergoing treatment for kidney failure. Significantly improving their quality of life, patients undergoing haemodialysis at home typically require less medication and have greater treatment flexibility with often much better clinical outcomes. Current hospital haemodialysis is restrictive and time consuming, with patients needing to come in to hospital three days a week, which often makes continuing in employment difficult. It also impacts greatly on quality of life, morbidity and mortality, despite the advances in technology.

The Manchester team provides its patients with the tools and know how required to make the transition to home haemodialysis, which allows more flexibility, with longer or more frequent sessions , enabling patients to fit dialysis around their lives. Many patients opt to undergo the treatment whilst asleep between three to five nights a week, which is less restrictive, safer and more convenient.

Since the introduction of home haemodialysis, patient experience has improved and it has resulted in superior clinical outcomes. It also brings financial savings, with costs up to 40% lower than hospital care. More than 175 patients so far have been trained in this programme to be independent on home haemodialysis, with increasing numbers joining every day.

Dr Sandip Mitra, Consultant Renal Physician at the Manchester Royal Infirmary said: "The whole team is delighted to have been shortlisted for this NICE award. The programme has been driven by patient choice and motivation, with results confirming that home haemodialysis is a viable treatment option that should be made available to all those who might benefit. We hope that the project will inspire more programmes across the country to offer this choice of treatment to suitable patients on dialysis"

Val Moore, Implementation Programme Director at NICE said: "Despite home haemodialysis improving outcomes for patients, uptake across the country is still very low. This programme in Manchester is a real example of innovative thinking driving up patient care and delivering excellent results. I congratulate the team in Manchester and all those shortlisted."

A patient using home haemodialysis said: "When I was faced with hospital dialysis, I lost a lot of self esteem, felt low and lost interest in a lot of things - it was like a downward spiral. Home dialysis has suddenly made me feel more interested, happier and relaxed."

The winner of the NICE Shared Learning Award will be announced at the NICE Annual Conference 2011, at the ICC in Birmingham on Tuesday 10 May 2011.

Notes

References

1. Haemodialysis is a process of removing waste products and excess fluid which build up in the body when the kidneys stop working.

2. The NICE Shared Learning Awards recognise and reward examples of how NICE guidance has been put into practice in the NHS, local authorities, voluntary and other organisations.

The three shortlisted projects are:

- Bringing the benefits of Home Haemodialysis Home - Central Manchester Foundation Trust.

- Statins for ischaemic heart disease: Excellence and equity - East London Clinical Effectiveness Group.

- Stop the Clot: Implementation of extended thromboprophylaxis in patients undergoing major abdominal and pelvic cancer surgery - Sheffield Teaching Hospitals NHS Trust.

The winner will be chosen by attendees at the NICE Annual Conference on Tuesday 10 May 2011 at the ICC in Birmingham. The winner will receive a trophy and runners-up will be presented with certificates.

Source:
NICE